Pharmacogenetics.

Slides:



Advertisements
Similar presentations
Genetics and Genomics in Clinical Medicine
Advertisements

Taking Research and Development to the Clinic: Issues for Physicians AAAS/FDLI Colloquium I Diagnostics and Diagnoses Paths to Personalized Medicine Howard.
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning” A Report of the American College of Cardiology Foundation Task Force on Clinical.
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
10/20/ The Pharmaceutical Industry and Their Influence on Pain Management in the ED J. David Haddox, DDS, MD VP, Risk Management & Health Policy.
For the Healthcare Provider
CZ5225 Methods in Computational Biology Lecture 9: Pharmacogenetics and individual variation of drug response CZ5225 Methods in Computational Biology.
Know Your Medications Dangers of mixing medications ProCare Hospice of Nevada RM VanDee RN, MSN.
“Empowerment At The Source of Treatment” Psychotropic & Unnecessary Medication Reduction: Rethinking Your Pathway To compliance.
Dr. Almut Nebel Dept. of Human Genetics University of the Witwatersrand Johannesburg South Africa Significance of SNPs for human disease.
Claudine Hughes Chief Pharmacist, NMIC. Medicines should be prescribed only when they are necessary, and in all cases the benefit of administering the.
Clinical Genotyping and Personalized Medicine Michael D. Kane, PhD (1) Associate Professor of Bioinformatics (2) University Faculty Scholar (3) Chair of.
Individualized Medicine Pharmacogentics
Individualized Medicine Pharmacogentics Right Dose. Right Time. First Time. Susan Kolyno, BA, CMA, Vantari Laboratory Representative
OPPORTUNITIES FOR RESEARCH IN PRIMARY CARE Jen Dumbleton Clinical Trial Manager University of Nottingham
Human Genomic Variation The Story of SNPs. Single Nucleotide Polymorphisms (SNPs)  In addition to variation in microsatellites (VNTRs), genetic variation.
Gender Competency Training for Medical Educators 28 th of April 2003 Evidence of gender difference and its clinical significance Ann-Maree Nobelius Faculty.
Kenneth Sisco, MD, PhD, FCAP Medical Director Quest Diagnostics
The United States & Heart Disease Presented today by; Matt Lorup, Keith Arline, & Nick Knight.
University of Utah Department of Human Genetics Pharmacogenomics Louisa A. Stark, Ph.D. Director.
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications Mark Bleackley MEDG 505 March.
Health in America? Discuss three issues with a classmate? Costs, access, quality, insurance, preventive medicine, alternative medicine, diseases.
An Update on NSAID Labeling and Data Review DSaRM Advisory Committee February 10, 2006 Sharon Hertz, M.D. Deputy Director Division of Anesthesia, Analgesia,
Sales Trainer for PGXL Laboratories
Implementing pharmacogenetics with CIPHER™ Personalized Medicine Program Property of PGxl Laboratories Kristen K. Reynolds, PhD VP Laboratory Operations.
Regulation of Promotion of Prescription Drugs Thomas W. Abrams, R.Ph., MBA Division of Drug Marketing, Advertising, and Communications Food and Drug Administration.
The University of Mississippi Medical Center
The National Prevention Strategy and Behavioral Health Care: Prevention Is Now RADM Peter J. Delany, Ph.D., LCSW-C Substance Abuse and Mental Health Services.
20 Beginning of the chapter
Introduction to Pharmacotherapy Ghada A Bawazeer. MSc, PharmD. BCPS King Saud University-College of Pharmacy Sept
“Empowerment At The Source of Treatment” Psychotropic & Unnecessary Medication Reduction: Rethinking Your Pathway To compliance.
ADVERSE EFFECTS OF DRUGS Phase II May Adverse Drug Reaction An adverse reaction to a drug is a harmful or unintended response. ADRs are claimed.
Foot and Ankle Specialist practicing for over 30 years in the Hudson Valley. Operates six successful practices in the New York Market. His passion has.
K NOWLEDGE S ERVICE E XPERIENCE Integrated Clinical Solutions.
E-prescribing is the computer based generation of filling medical prescriptions. The purpose of E-prescribing is to reduce the risks associated with traditional.
Hitetrapib – Eliminating Heart Disease Gillian Brazier Development Head, Cardiovascular Medicine.
Pharmacogenetics and Pharmacogenomics Eric Jorgenson 2/24/9.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: -relationship.
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
Genomics and Personalized Care
METHODS TO STUDY DRUG SAFETY PROBLEMS animal experiments clinical trials epidemiological methods –spontaneous reporting case reports case series –Post-Marketing.
Definitions. Clinical pharmacy is the branch of Pharmacy where pharmacists provide patient care that optimizes the use of medication and promotes health,
Personalized Medicine Dr. M. Jawad Hassan. Personalized Medicine Human Genome and SNPs What is personalized medicine? Pharmacogenetics Case study – warfarin.
Utility of Genotyping in Pharmaceutical Target (gene) Discovery and Drug Response Anne Westcott EST-Informatics.
Be a Partner with Your Physician Stephen TePastte M.D. Medical Director MESSA.
Introduction.
Copyleft Clinical Trial Results. You Must Redistribute Slides The American College of Cardiology Foundation / American Heart Association Clopidogrel Recommendations.
Adherence & the Role of Consumers & Carers in Medication Management Sue Henderson.
How Genetic Variants Impact the Safety and Effectiveness of Drugs Pharmacogenetics © PGXL Laboratories.
Applying New Science to Drug Safety Janet Woodcock, M.D. Acting Deputy Commissioner for Operations April 15, 2005.
Complex Medical Patients Wayne Katon, MD.  Definition: Illnesses with high prevalence, high comorbidity and bidirectional adverse interactions Examples:
Dr.SHIVA KUMAR.S Professor of medicine Stanley medical college.
Pharmacogenomics: Improving the Dynamic of Care in Medication Management 1.
Drug efficacy is questioned.. Variation in drug responses.
1 One Year Post Exclusivity Adverse Event Review: Glyburide-Metformin Pediatric Advisory Committee Meeting February 14, 2005 Hari Cheryl Sachs, MD, FAAP.
Pharmacogenetics/Pharmacogenomics. Outline Introduction  Differential drug efficacy  People react differently to drugs Why does drug response vary?
New research areas in personalised medicines
Medication therapy management
Dawn Dowding PhD RN VNSNY Professor of Nursing
PGx Logical Overview.
Pharmacogenomics Rita Leone, RN, MSN, CMSRN.
Prescription Decision Support For Primary Care
Mahla sattarzadeh Kerman University of Medical Sciences
Pharmacovigilance (PV)
68.3 million errors (28% of total) cause moderate or serious harm
Pharmacogenomics Genes and Drugs.
Personalised Medicine ‘into the future’
Dawn Dowding PhD RN VNSNY Professor of Nursing
The Case for Routine CYP2C19 ( Plavix® ) Genetic Testing
Presentation transcript:

Pharmacogenetics

What is Pharmacogenetics? Pharmacogenetics is the clinical testing of the genetic variations (SNP’s) that give rise to differing responses to drugs. Genetic differences in metabolic pathways can affect an individuals response to drugs in terms of therapeutics effect as well as adverse events.

Drug Metabolism Over 80% of today’s medications are metabolized by the Cytochrome P450 enzymes

Types of Metabolizers Rapid metabolizer Normal metabolizer Intermediate metabolizer Poor metabolizer How is the metabolizing function determined? Based on variations with in the gene called SNP’s (Single Nucleotide Polymorphisim)

How is pharmacogentics changing medicine? The one size fits all approach to prescribing is moving towards a more personalized method. Phamacogentics can help determine drug-drug interactions Testing can improve prescription medication efficacy Knowing how a patient will metabolize a drug can minimize the need to physicians to use the “trial and error” process of prescribing medications

Who should be tested? Anyone being prescribed a new medication Anyone who has experienced and ADR Anyone experiencing lack of efficacy Anyone on multiple medications

Common Conditions Mental health Pain Management Post MI Surgery Acid Reflux Cancer Heart Disease Heart Failure High Blood Pressure Migraines Peptic Ulcers High Cholesterol ADHD

Important Statistics Two-thirds of all patient visits result in a drug prescription Adverse Drug Events annually account for: 2 Million Serious Event 100,000 Deaths (4th leading cause of death in US)1 10% of prescription drugs now have PGx block box warnings2 1 http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm114848.htm 2 New England Journal of Medicine, July 22, 2010

What makes us different? Our report is the most comprehensive report on the market and will aid physicians when prescribing by providing…. Metabolism levels Drug to Drug interactions Alerts (perform urine drug tox) Decision options (ex: dosing recommendations and alternative medications.) Physicians will be provided a list of drugs within the same class that the patient metabolizes properly. We provide easy to navigate tools at the point of care to aid the physician in prescribing the right medication using established evidence.

Panels Currently Available Pain Psych

Panels Continue Cardiovascular